Böcker D, Breithardt G
Department of Cardiology and Angiology, Westfälische Wilhelms-University of Münster, Germany.
Am J Cardiol. 1999 Mar 11;83(5B):83D-87D. doi: 10.1016/s0002-9149(98)01039-x.
Ventricular tachycardia and ventricular fibrillation account for a substantial proportion of all deaths in patients with heart failure. Of currently available therapies, amiodarone and the implantable cardioverter defibrillator (ICD) appear to have the greatest potential to decrease sudden death in heart failure. In this article, the presently available information on the relative role of antiarrhythmic drugs, with a focus on amiodarone and ICDs in heart failure, is reviewed.
室性心动过速和心室颤动在心力衰竭患者的所有死亡原因中占很大比例。在目前可用的治疗方法中，胺碘酮和植入式心脏复律除颤器（ICD）似乎在降低心力衰竭患者猝死风险方面具有最大潜力。本文综述了关于抗心律失常药物相对作用的现有信息，重点关注胺碘酮和ICD在心力衰竭中的作用。
